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Purpose: Primary synovial sarcoma of the penis is extremely rare. We
report a case of synovial sarcoma initially discovered as a painless penile
mass with no image evidence of distal metastasis. Synovial sarcoma was
reported in the ﬁnal pathology.
Materials and Methods: A 59-year-old male patient is a case of panic
disorder under alprazolam treatment for 4 years. He came to our outpa-
tient department for gradual enlargement of penile mass in recentmonths.
He is a married man without circumcision. The mass was painless,
spherical, and movable over penile base, without skin abnormality or
infection signs. Computed tomography revealed a 3.2 cm hypodense mass
lesion over left side of corpus cavernosum without enlargement of pelvis
or retroperitoneal lymph nodes. Partial penectomy with bilateral inguinal
lymph node dissection was performed. Synovial sarcoma within tunica
abluginea (pT2) was reported in the ﬁnal pathology.
Results: To our knowledge; this is the ﬁrst case of primary synovial sar-
coma of penis in Taiwan.
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This 78 years old manwho was under regular follow-up post transurethral
rsection of prostate gland. During last cystoscope, tumor biopsy was done
and the pathologic report reveal possibility of urothelial carcinoma with
glandular differentiation, which primary adenocarcinoma or secondary
adenocarcinoma involvement especially colorectal origin may be consid-
eration on July, 2015.
Afterward, we arranged MRI for tumor staging and it reveals T3N0M0,
Stages III. Then, after explain to patient, transurethral resection of bladder
tumor was performed on Aug, 2015. The ﬁnal pathologic report reveals
adenocarcinoma arising from urinary bladder. We also arranged colon
scope which reveals negative ﬁnding. PET scan reveals no uptake for
gastrointestinal tract.
As exclude colorectal origin of adenocarcinoma, patient is under radio-
therapy and chemotherapy for adneomcarcinoma currently.
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Purpose: Glutathione S-transferases (GSTs) play an important role in the
detoxiﬁcation of polycyclic aromatic hydrocarbons and aromatic amines,
the toxic substances contained in cigarettes. GST Omega 1 (GSTO1) not
only utilizes glutathione in conjugation reaction but also contributes to the
biotransformation of several xenobiotics. A single nucleotide poly-
morphism (Ala- 140Asp) of GSTO1 gene causing variations in enzyme
activity may inﬂuence individual susceptibility to bladder cancer (BC). It is
hypothesized that genetic polymorphism of GSTO1 gene has an effect on
BC risk in particular by interacting with cigarette smoking.
Materials and Methods: A total of histopathologically conﬁrmed 300 BC
patients and 300 cancer-free controlswere recruited fromFebruary 2002 to
February 2009. Genotyping of the GSTO1 Ala140Asp polymorphism was
deter-mined using a polymerase chain reaction-restricted fragment lengthpolymorphism (PCR-RFLP)method. The odds ratio (OR) and 95% conﬁdence
interval (CI)were calculated as ameasureof the combined effectof cigarette
smoking and the GSTO1 Ala140Asp polymorphism on BC risk.
Results: We found that study subjects with the GSTO1 Ala/Ala genotype
have a signiﬁcantly increased BC risk (OR¼ 1.5; 95% CI¼ 1.1e2.7). A sta-
tistically signiﬁcant increased BC risk was also found in ever smokers with
the GSTO1 Ala/Ala genotype (OR¼ 4.9; 95%CI¼ 2.8e9.7).
Conclusions:Thisstudyprovidesanepidemiologic evidenceofa signiﬁcantly
increased BC risk among ever smokers with the GSTO1 Ala/Ala genotype.
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Purpose: The presence of lymph nodes within the prostatic anterior fat
pad (PAFP) has been noted in several reports. Metastatic cancer can be
found in PAFP lymph nodes. The characteristics of patients with PAFP
lymph node metastasis are not well described in Taiwanese patients.
Materials and Methods: From December 2006 to May 2014, 770 consec-
utive patients received robot-assisted radical prostatectomy(RARP) with
PAFP dissection bya single surgeon, Yen-ChuanOu.Mean agewas 65.1± 7.1
years. PAFP was removed for pathological examination to evaluate the
presence of lymphoid tissue and the involvement of prostate cancer.
Results: Among these 770 patients, 61(7.92%) patients were detected to
have 1 to 3 PAFP lymph nodes. 52 patients had one node, 7 patients had
two nodes, and 2 patients had three nodes. 6(0.82%) patients had positive
metastasis. In these 6 patients, 2 patients had PAFP metastases only and
the other 4 patients had concomitant pelvic lymph nodes metastases. The
other 55 patients had PAFP nodes but tested negative for malignancy.
Conclusions: Prostate cancer with metastases to the PAFP nodes has
positive correlation with patients who had a high risk of prostate cancer
preoperatively. The removal of the PAFP can facilitate the dissection of the
prostate apex and bladder neck, and can also result in pathological
upstaging if metastasis was present.Moderated Poster-4
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UROLITHIASIS IS ASSOCIATED WITH HIGHER PREVALENCE OF LOW
SERUM TESTOSTERONE LEVEL IN PATIENTS WITH ERECTILE
DYSFUNCTION
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Purpose: Both stone disease and erectile dysfunction (ED) are currently
considered as systemic diseases which may associate with
several systemic risk factors, such as hypertension (HTN), diabetes
mellitus (DM), dyslipidemia, smoking, obesity, and hypogonadism. The
aim of this study is to evaluate the prevalence of urolithiasis in
patients with ED, and to show which risk factors may relate to stone
formation.
Materials and Methods: From May 2014 to September 2015, total 186
patients presented to our out-patient clinic with chief complaint of ED
were prospectively enrolled. The clinical characteristics, underlying dis-
eases, current medications, IIEF-5 questionnaire, biochemical proﬁles and
self-report history of urolithiasis were collected. We further divided these
patients into stone positive group and stone negative group. The Fisher’s
exact test were used to evaluate the different prevalence of risk factors
between these two groups.
Results: Of the 186 patients, 21 (11.3%) reported history of urolithiasis, and
were divided in the stone positive group. The other 165 patients were in
